Na Zhang

10.3k total citations · 2 hit papers
244 papers, 7.0k citations indexed

About

Na Zhang is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Na Zhang has authored 244 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Molecular Biology, 44 papers in Immunology and 24 papers in Genetics. Recurrent topics in Na Zhang's work include Wheat and Barley Genetics and Pathology (10 papers), Bone Metabolism and Diseases (9 papers) and CRISPR and Genetic Engineering (8 papers). Na Zhang is often cited by papers focused on Wheat and Barley Genetics and Pathology (10 papers), Bone Metabolism and Diseases (9 papers) and CRISPR and Genetic Engineering (8 papers). Na Zhang collaborates with scholars based in China, United States and Canada. Na Zhang's co-authors include Sheng‐Cai Lin, Jiahuai Han, Juan Lin, Jing Shao, Duanwu Zhang, Meng-Qiu Dong, Ling Wang, Da‐Jin Li, Xiao‐Qi Yu and Junxia Xie and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Na Zhang

230 papers receiving 6.9k citations

Hit Papers

RIP3, an Energy Metabolism Regulator That Switches TNF-In... 2009 2026 2014 2020 2009 2024 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Na Zhang China 37 3.8k 1.3k 852 841 754 244 7.0k
Tingze Feng China 7 4.4k 1.2× 1.4k 1.1× 793 0.9× 872 1.0× 1.3k 1.8× 10 8.0k
Wenli Tang China 16 5.4k 1.4× 1.6k 1.2× 864 1.0× 839 1.0× 1.4k 1.9× 38 9.7k
Meijun Chen China 24 4.9k 1.3× 1.4k 1.1× 806 0.9× 872 1.0× 1.5k 2.0× 119 9.5k
Li Zhan China 22 5.0k 1.3× 1.5k 1.2× 818 1.0× 914 1.1× 1.5k 2.0× 68 9.2k
Shuangbin Xu China 15 5.0k 1.3× 1.5k 1.2× 963 1.1× 971 1.2× 1.4k 1.9× 30 9.1k
Junjun Wang China 56 4.5k 1.2× 1.0k 0.8× 888 1.0× 635 0.8× 519 0.7× 351 11.9k
Xiaobing Li China 44 2.4k 0.6× 889 0.7× 668 0.8× 601 0.7× 713 0.9× 301 6.8k
Lili Zhou China 49 4.1k 1.1× 711 0.6× 698 0.8× 368 0.4× 859 1.1× 295 8.8k
Lu Zhang China 37 6.1k 1.6× 986 0.8× 1.2k 1.4× 1.1k 1.2× 1.3k 1.7× 329 10.1k
Siqi Liu China 41 4.5k 1.2× 2.5k 2.0× 538 0.6× 646 0.8× 899 1.2× 299 8.4k

Countries citing papers authored by Na Zhang

Since Specialization
Citations

This map shows the geographic impact of Na Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Zhang more than expected).

Fields of papers citing papers by Na Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Zhang. The network helps show where Na Zhang may publish in the future.

Co-authorship network of co-authors of Na Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Na Zhang. A scholar is included among the top collaborators of Na Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Zhang. Na Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Juan, Na Zhang, Wenjing Ren, et al.. (2025). Effect of chronic intermittent hypoxia on hippocampal lipid metabolism in mice: A targeted lipidomics study. Brain Research Bulletin. 224. 111319–111319.
2.
Wang, Fei, et al.. (2025). 20(S)-ginsenoside Rg3 suppresses gastric cancer cell proliferation by inhibiting E2F-DP dimerization. Phytomedicine. 141. 156740–156740. 1 indexed citations
3.
Yu, Yang, Tong Li, Wenying Xu, et al.. (2024). PTPN22 and the pathogenesis of ulcerative colitis: Insights into T cell differentiation and the JAK/STAT signaling pathway. Cellular Signalling. 127. 111551–111551. 2 indexed citations
4.
Zhang, Na, et al.. (2024). A palmitoylation–depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis. Nature Cell Biology. 26(5). 757–769. 72 indexed citations breakdown →
5.
Zhang, Na, Yilin Wu, Yongxiang Su, et al.. (2024). Upconversion nanoparticles incorporated with three-dimensional graphene composites for electrochemical sensing of baicalin from natural plants. RSC Advances. 14(48). 36084–36092. 3 indexed citations
6.
Xu, Fan, et al.. (2024). CNDP1 Suppresses the Malignant Behavior of Hepatoma Cell via Restricting PI3K-AKT-mTOR Activation. Current Cancer Drug Targets. 25(2). 131–143. 1 indexed citations
7.
Zhang, Na, et al.. (2023). Development of a cellular automata-based distributed hydrological model for simulating urban surface runoff. Journal of Hydrology. 627. 130348–130348. 6 indexed citations
8.
Guan, Suzhen, et al.. (2023). Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis. Frontiers in Cardiovascular Medicine. 10. 1175174–1175174. 33 indexed citations
9.
Zhang, Na, Guanghao Zhu, Yufan Fan, et al.. (2023). Functional Imaging and Inhibitor Screening of Human Pancreatic Lipase by a Resorufin-Based Fluorescent Probe. Biosensors. 13(2). 283–283. 4 indexed citations
10.
Zhang, Na, Jing Xing, Shuhua Zhang, et al.. (2023). UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis. Nature Communications. 14(1). 14 indexed citations
11.
Zhang, Na, Wen Zhang, Yilin Wu, et al.. (2023). Upconversion nanoparticles anchored MnO2 nanosheets for luminescence “turn on” detecting hydrogen peroxide. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 299. 122819–122819. 8 indexed citations
12.
Han, Yikai, Xin Wang, Yong Zhang, et al.. (2022). EIF3B stabilizes PTGS2 expression by counteracting MDM2‐mediated ubiquitination to promote the development and progression of malignant melanoma. Cancer Science. 113(12). 4181–4192. 2 indexed citations
14.
Zhang, Na, et al.. (2022). Lipid Giant Vesicles Engulf Living Bacteria Triggered by Minor Enhancement in Membrane Fluidity. Nano Letters. 23(1). 371–379. 7 indexed citations
16.
Jiang, Jianjun, et al.. (2020). Tumor necrosis factor-α requires Ezrin to regulate the cytoskeleton and cause pulmonary microvascular endothelial barrier damage. Microvascular Research. 133. 104093–104093. 11 indexed citations
17.
Zhao, Ji, Hongqiang Chen, Yan Li, et al.. (2019). Epigenetic silencing of ALX4 regulates microcystin-LR induced hepatocellular carcinoma through the P53 pathway. The Science of The Total Environment. 683. 317–330. 24 indexed citations
18.
Qi, Ruilian, Pengbo Zhang, Jian Liu, et al.. (2018). Peptide Amphiphiles with Distinct Supramolecular Nanostructures for Controlled Antibacterial Activities. ACS Applied Bio Materials. 1(1). 21–26. 46 indexed citations
19.
Zhang, Na, Ruilian Qi, Yao Chen, et al.. (2018). Partition of Glutamic Acid-Based Single-Chain and Gemini Amphiphiles into Phospholipid Membranes. Langmuir. 34(45). 13652–13661. 7 indexed citations
20.
Zhang, Duanwu, Jing Shao, Juan Lin, et al.. (2009). RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis. Science. 325(5938). 332–336. 1566 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026